
2 - 10 employees
Founded 2025
𧬠Biotechnology
π Pharmaceuticals
Biotechnology β’ Pharmaceuticals
Quetzal Therapeutics is a clinical-stage company developing oral and formulation-engineered therapies to transform treatment of rare hematologic malignancies and other underserved rare diseases. Its lead candidate, QTX-2101, is an investigational oral formulation of arsenic trioxide in Phase III for acute promyelocytic leukemia (APL), intended to replace IV infusion-based regimens and reduce patient treatment burden. The company also pursues a preclinical program, QTX-2102, aimed at novel antifungal and antiparasitic therapies for rare infectious diseases, and emphasizes proprietary delivery technologies and a stability-first approach to improve tolerability, access, and compliance.
π‘ We watch Quetzal Therapeutics's careers page
Several times a day
how often we check
2
roles posted in the last 30 days
Selected: πΊπΈ United States β Remote USA.
Selected: π Date Added.
π₯ 34 minutes ago
Senior Director of Quality building scalable GxP systems for Quetzal Therapeutics, a rare-disease biopharmaceutical company. Leading clinical quality, supplier oversight, inspections, and regulatory readiness.
π₯ 34 minutes ago
Director of Program Management leading integrated plans, regulatory submissions, and launch readiness. Advancing rare-disease therapies at biopharmaceutical company Quetzal Therapeutics.